Another possibility is that GM-CSF-producing T cells are more abundant during the early stages of infection, as part of an initial Th17 response (73), and skewing toward a Th1 response may lead to the loss of GM-CSF production by CD4+ T cells (74). The gene discussed is CSF2; the disease is infection.